Advertisement
Canada markets open in 6 hours 50 minutes

  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CAD/USD

    0.7331
    +0.0007 (+0.10%)
     

  • CRUDE OIL

    83.99
    +0.42 (+0.50%)
     

  • Bitcoin CAD

    87,762.41
    +31.66 (+0.04%)
     

  • CMC Crypto 200

    1,391.07
    -5.47 (-0.39%)
     

  • GOLD FUTURES

    2,351.10
    +8.60 (+0.37%)
     

  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • NASDAQ futures

    17,774.50
    +207.00 (+1.18%)
     

  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     

  • FTSE

    8,078.86
    +38.48 (+0.48%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6827
    +0.0006 (+0.09%)
     

Regeneron Pharmaceuticals (REGN) Jumps: Stock Rises 6.3%

Zacks Equity Research
·2 min read

Regeneron Pharmaceuticals, Inc. REGN was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $516.15 to $577.12 in the past one-month time frame.

The company has seen four positive estimate revisions in the past month, while its Zacks Consensus Estimate for the current quarter has also moved higher in the same time frame, suggesting that more solid trading could be ahead for Regeneron Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Regeneron Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Regeneron Pharmaceuticals, Inc. Price

Regeneron Pharmaceuticals, Inc. Price
Regeneron Pharmaceuticals, Inc. Price

Regeneron Pharmaceuticals, Inc. price | Regeneron Pharmaceuticals, Inc. Quote

ADVERTISEMENT

Another stock worth considering in the Medical – Biomedical and Genetics industry is Akcea Therapeutics, Inc. AKCA which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Hottest Tech Mega-Trend of All

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>






Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
 
Akcea Therapeutics, Inc. (AKCA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.